×
About 2,333 results

ALLMedicine™ Tardive Dyskinesia Center

Research & Reviews  573 results

A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
https://clinicaltrials.gov/ct2/show/NCT03813238

Jun 22nd, 2022 - CP (cerebral palsy) refers to a group of neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination. CP is caused by damage to or abnormalities inside the developing brain that dis...

Reduction of Demoralization After Treatment of TD With Valbenazine
https://clinicaltrials.gov/ct2/show/NCT05053321

May 24th, 2022 - This will be an Investigator-initiated, prospective, single center, interventional pilot study. This study will examine the feasibility of a larger study aimed at determining if there is an association between the improvement in tardive dyskinesia...

Alzheimer Disease Clinical Presentation
http://emedicine.medscape.com/article/1134817-clinical

May 9th, 2022 - History Patients with Alzheimer disease (AD) most commonly present with insidiously progressive memory loss, to which other spheres of cognition are impaired over several years. This loss may be associated with slowly progressive behavioral change...

Movement Disorders and Mortality in Severely Mentally Ill Patients: The Curacao Extrapy...
https://doi.org/10.1093/schbul/sbac037
Schizophrenia Bulletin; Willems AE, Mentzel CL et. al.

Apr 30th, 2022 - There is a substantial gap in life expectancy between patients with severe mental illness (SMI) and the general population and it is important to understand which factors contribute to this difference. Research suggests an association between tard...

Development of the MIND-TD Questionnaire as a Screening Tool for Tardive Dyskinesia.
https://doi.org/10.1017/S1092852922000323
CNS Spectrums; Lundt L, Jain R et. al.

Apr 29th, 2022 - MIND-TD is a collaboration of healthcare professionals (HCPs) who are committed to raising awareness of tardive dyskinesia (TD), a persistent and potentially disabling movement disorder associated with prolonged exposure to antipsychotics and othe...

see more →

Guidelines  1 results

Revisiting the Abnormal Involuntary Movement Scale: Proceedings From the Tardive Dyskin...
https://doi.org/10.4088/JCP.17cs11959
The Journal of Clinical Psychiatry; Kane JM, Correll CU et. al.

May 10th, 2018 - To provide an historic overview of the Abnormal Involuntary Movement Scale (AIMS) in clinical trials of tardive dyskinesia (TD), with current recommendations for analyzing and interpreting AIMS data. Seven psychiatrists and 1 neurologist were sele...

see more →

Drugs  150 results see all →

Clinicaltrials.gov  73 results

A Study of TEV-50717 (Deutetrabenazine) for the Treatment of Dyskinesia in Cerebral Palsy in Children and Adolescents
https://clinicaltrials.gov/ct2/show/NCT03813238

Jun 22nd, 2022 - CP (cerebral palsy) refers to a group of neurological disorders that appear in infancy or early childhood and permanently affect body movement and muscle coordination. CP is caused by damage to or abnormalities inside the developing brain that dis...

Reduction of Demoralization After Treatment of TD With Valbenazine
https://clinicaltrials.gov/ct2/show/NCT05053321

May 24th, 2022 - This will be an Investigator-initiated, prospective, single center, interventional pilot study. This study will examine the feasibility of a larger study aimed at determining if there is an association between the improvement in tardive dyskinesia...

Treatment of Psychosis and Agitation in Alzheimer's Disease
https://clinicaltrials.gov/ct2/show/NCT02129348

Apr 22nd, 2022 - Symptoms of psychosis or agitation are common in Alzheimer's disease. These symptoms are associated with distress for the patient, an increased burden for caregivers, more rapid cognitive decline, greater risk of institutionalization and mortality...

Randomized Controlled Trial of Pyridoxine for Tardive Dyskinesia
https://clinicaltrials.gov/ct2/show/NCT03287778

Apr 13th, 2022 - Overview of Procedures: All procedures will be conducted at either the University of North Carolina Hospitals in Chapel Hill, or at the North Carolina Psychiatric Research Center (NCPRC), a specialized program of the University of North Carolina C...

Individualized Repetitive Transcranial Magnetic Stimulation for Auditory Verbal Hallucinations
https://clinicaltrials.gov/ct2/show/NCT05319080

Apr 8th, 2022 - The large majority of patients with schizophrenia (Sz) experience auditory verbal hallucinations (AVH) as a core feature of their disorder. Treatment-resistant auditory verbal hallucinations (AVH) affect a third of patients with schizophrenia and ...

see more →

News  133 results

Fast Five Quiz: How Much Do You Know About Tardive Dyskinesia?
https://www.medscape.com/viewarticle/910550

Apr 22nd, 2022 - Tardive dyskinesia (TD), according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), is a medication-induced movement disorder that causes involuntary repetitive muscle movements in the face, neck, arms, and legs...

Tardive Dyskinesia Drug Safe, Effective for Huntington's Chorea
https://www.medscape.com/viewarticle/972355

Apr 19th, 2022 - A drug currently approved for tardive dyskinesia (TD) is also effective at treating Huntington's disease (HD)–associated chorea, a movement disorder that affects most patients with HD, new phase 3 trial results show. Valbenazine is in the same cla...

Fast Five Quiz: Tardive Dyskinesia Risk Factors
https://www.medscape.com/viewarticle/945983

Apr 11th, 2022 - Tardive dyskinesia (TD) is a severe, often irreversible movement disorder caused by prolonged exposure to certain medications. The clinical manifestations of TD include abnormal movements of the tongue, lips, face, trunk, and extremities. The invo...

Novel Drug Significantly Reduces Tics in Tourette's ― Without Side Effects
https://www.medscape.com/viewarticle/971335

Mar 31st, 2022 - An investigational drug that blocks the dopamine-1 (D1) receptor reduces tics and is safe and well tolerated in children with Tourette syndrome (TS), a new study shows. Importantly, unlike current medications for the disorder, ecocipam does not le...

Top strategies for preventing tardive dyskinesia
https://www.mdedge.com/psychiatry/article/251979/movement-disorders/top-strategies-preventing-tardive-dyskinesia
Doug Brunk

Feb 18th, 2022 - LAS VEGAS – In the opinion of Christoph U. Correll, MD, tardive dyskinesia (TD) “has been somewhat forgotten” by psychiatrists because the risk of patients developing the condition is considered to be significantly lower with second-generation ant.

see more →

Patient Education  3 results see all →